What amount sold does Tolerance Bio Inc. report in Form D filings?

The latest linked filings report $15.1M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Tolerance Bio Inc.'s most recent SEC filing?

Tolerance Bio Inc.'s most recent Form D filing was on 2026-06-18.

How many investors does Tolerance Bio Inc. have?

The most recent Form D filing lists 13 investor(s).

What type of securities does Tolerance Bio Inc. offer?

Tolerance Bio Inc.'s SEC Form D filings indicate equity offerings.

Tolerance Bio Inc.

CIK: 0002075488·Biotechnology·PHILADELPHIA, PA·Corporation·Founded 2023

Reported Sold

$15,101,584

Total Filings

Identified Offerings

Last Filed

Jun 18, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jun 18, 2026Form D — New notice

Reported sold: $15,101,584 · Target: Indefinite

Rule 506(b)·13 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$15,101,584

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 18, 2026	New	Indefinite	$15,101,584	13

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

BioLattice Ophthalmics, Inc,

Biotechnology

Offering target: $3,310,000

Filed Oct 28, 2026